Deirdre Cogan

  1. Defining ocrelizumab's role within the MS treatment landscape

    Ocrevus (ocrelizumab) was approved in the US by the FDA in March 2017 for the treatment of adults with relapsing or primary progressive forms of MS, based on three clinical trials.

    ocrelizumab MS treatment

    Read more »
  2. Trailblazing Amsterdam’s Canals

    Amsterdam leads European cities as top tech destination and why it’s only natural that it is home to TheSocialMedwork.

    Amsterdam innovation health

    Read more »
  3. Edaravone availability in the US - one month to go

    As we await the arrival of edaravone to US pharmacies, patients can access edaravone now through TheSocialMedwork.edaravone best price

    Read more »
  4. You can’t stop the wave, but you can learn to surf

    What makes a startup succeed?

    startup health thesocialmedwork

    Read more »
  5. PrEP for HIV Prevention

    With recent drops in new HIV diagnoses being linked to buying PrEP through online buyers clubs, the addition of PrEP to the WHO's essential medicine list, and the recent approval of generic PrEP in the US - here’s what you need to know.

    PrEP for HIV Prevention

    Read more »
  6. 5 things you need to know about multiple sclerosis (MS)

    Get the latest news on MS research, the FDA approval of Ocrevus (ocrelizumab) for both relapsing and progressive forms of MS, insights and resources.

    multiple sclerosis

    Read more »
  7. Another high price tag for Duchenne muscular dystrophy treatment

    PTC Therapeutics announce the launch of Emflaza for the treatment of Duchenne muscular dystrophy (DMD) within the coming weeks, with an expected net price of $35,000.

    Read more »
  8. The pricing controversy surrounding Duchenne muscular dystrophy (DMD) treatment

    The latest events surrounding the pricing of a Duchenne muscular dystrophy (DMD) treatment

     Duchenne muscular dystrophy (DMD) treatment price

    Read more »
  9. A look back, a step forward

    Last Thursday morning introduced us to spring, and what an entrance it made. The sun was shining, commuters passed each other with smiles, and the faint hum of summer could be heard for miles. 

    The Social Medwork team

    Read more »
  10. Australia’s Pharmaceutical Benefits Scheme (PBS) announce new treatments and price cuts for over 1000 medications

    The PBS, Australia’s national program responsible for providing subsidised prescriptions, has announced the addition of several new medicines

    globe Australia

    Read more »
  11. Marriages, businesses, and lots of bubbles!

    How our community celebrated remission!

    bride tossing flowers

    Read more »
  12. Promising results for cancer-immunotherapies revealed!

    Impressive results have been published last week regarding two new immunotherapies. 

    Lab Image

    Read more »